Navigation Links
New app widens opportunities for dementia assessments
Date:7/8/2014

A team of clinicians from Plymouth, UK, and Sydney, Australia, have today (Wednesday 9th July 2014 UK, Thursday 10th July Australia) launched ACEmobile - a free-to-use app to support the assessment of dementia, worldwide.

ACEmobile is the first of its kind; an iPad-based tool that supports the assessment of dementia. The tool provides support through the whole process, meaning more members of the clinical team can feel confident carrying out this type of assessment. Designed by clinicians for clinicians, ACEmobile also collects secure and anonymised data to allow the team to improve our understanding of dementia and ability to detect it earlier.

Formed as a not-for-profit venture, the clinical team who developed ACEmobile intend this to be the first step in supporting the growth of an international community of like-minded scientists and healthcare professionals eager to support the project in developing and testing new, and more sensitive, computerised instruments to help in the early diagnosis and evaluation of medical treatments for dementia.

ACEmobile is currently an iPad-based tool that guides the user through the Addenbrooke's Cognitive Examination (ACE-III). The ACE-III is one of the most popular and commonly-used paper and pencil screening tools for dementia. The app removes the need for clinicians to learn the ACE-III manual and it also automatically calculates patients' scores and creates a report to go into their medical records.

The creators have designed the app to make dementia assessment easier and more reliable for NHS staff and health professionals around the world. The research team will collect anonymised information from each assessment conducted using the app, with a plan to improve the sensitivity of ACEmobile for earlier dementia diagnosis and in assessing the effect of new medications as they are tested. One of the major factors holding back the development of new treatments for dementia is the relative insensitivity of currently used methods.

The ACEmobile development group are now looking to the future and are exploring the option of a charitable community that will safeguard the long-term availability of the app as a freely available resource. It is hoped that this community will support additional developments with a similar positive impact on patients and healthcare provision. With clinicians, commercial organisations and patient groups already excited about the potential benefits of ACEmobile it is hoped this can be harnessed to support the app and additional developments. The project has already received external funding from the NIHR.

ACEmobile represents a potential significant step forward in the world of dementia research since it is being provided to the NHS and research bodies for free and the developers have no intention of generating commercial profit. A test sample of clinicians has had advance use of ACEmobile and the feedback has been unanimously positive. Dr. Pinkser, working in a Neuropsychology in Brisbane commented: "We found the app to be extremely self-explanatory and easy to use, and we were very impressed with the reporting format."

Dr. Greg Savage from Macquarie University, Sydney, said: "I highly recommend this clever reincarnation of the ACE-III on a tablet-based platform. Its user-friendly instructive interface and scoring features should make it an even more popular cognitive screening instrument."

Dr. Nick Cartmell, a GP from Ashburton Surgery in Devon, commented: "The setup is brilliant. The scoring system is clear and the export options ideal."

The development of ACEmobile has been a collaboration between Professor John Hodges (Neuroscience Research Australia), Dr Rupert Noad (Plymouth Hospitals NHS Trust), Dr Craig Newman and Professor John Zajicek (Plymouth University Peninsula Schools of Medicine and Dentistry) and has been supported by funding from an NIHR Programme Grant for the Study of Clinical Trials in Neurodegenerative Diseases, Plymouth Hospitals NHS Trust and the NIHR Collaboration for Leadership in Applied Health Research and Care South West Peninsula (PenCLAHRC).


'/>"/>

Contact: Andrew Gould
andrew.gould@plymouth.ac.uk
University of Plymouth
Source:Eurekalert  

Related medicine news :

1. Chanakya Research widens its scope to include law dissertation help service
2. IU study: Death of public figures provides important opportunities for health education
3. Internists review progress, challenges and opportunities
4. Global Ostomy Care Industry Trend & 2017 Opportunities Analyzed in New Research Study at MarketReportsOnline.com
5. Indexed Universal Life Insurance Offered at EQUOTE Providing Opportunities, Protection and Security to the American Family
6. UK Clinical Chemistry and Immunodiagnostics Market Opportunities Discussed in New VPG Report Published at MarketPublishers.com
7. GYMGUYZ Mobile Personal Training Company Opens New Franchising Opportunities
8. Trenton Health Team Acts on ACO Opportunities
9. Personal Accident and Health Insurance in Russia, Key Trends and Opportunities to 2017
10. Multiple Sclerosis (MS) Industry Trends and 2018 Market Opportunities Analyzed in New Research Report at MarketReportsOnline.com
11. Medical research needs kids, but two-thirds of parents unaware of opportunities
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New app widens opportunities for dementia assessments
(Date:8/16/2019)... ... , ... The clinical trial supply chain landscape is constantly shifting, and clinical ... In Time Manufacturing Solutions Manager at Almac Clinical Services , Natalie Balanovsky, in ... BST/UK) on a journey through time as it relates to clinical trial supply. ...
(Date:8/16/2019)... ... August 16, 2019 , ... Dr. Demetri Arnaoutakis, ... esteemed Haute Beauty Network. , The Haute Beauty Network, well known for its ... as a hair restoration expert and our newest addition to the Haute Beauty ...
(Date:8/15/2019)... (PRWEB) , ... August 15, 2019 , ... With many students either starting college for ... for this particular demographic. According to the CDC , “there are about 20 million ... are in people between the ages of 15 and 24. Young people are at greater ...
(Date:8/14/2019)... ... 14, 2019 , ... Teguar Corporation has claimed the #3719 position on the ... established as a mark of success for some of Americas top companies and has ... list in 2015, 2016 and 2017. This year, Teguar secured a spot on the ...
(Date:8/14/2019)... (PRWEB) , ... August 15, 2019 , ... ... first international clinic in Tijuana Mexico. R3 Stem Cell International is offering regenerative ... licensed in Mexico. , A full procedure costs only $2950, which includes a ...
Breaking Medicine News(10 mins):
(Date:8/21/2019)... Colo. (PRWEB) , ... August 21, 2019 , ... ... improving patron experience by lowering pool chemical use with Clear Comfort’s Advanced Oxidation ... is able to save significant chemical expense dollars, simplify its water care protocol ...
(Date:8/19/2019)... ... August 19, 2019 , ... Sheba Medical Center ... of research validating the clinical impact of MedAware’s machine learning-enabled patient safety platform ... in the Journal of American Medical Informatics Association (JAMIA) in a ...
(Date:8/17/2019)... ... 17, 2019 , ... The American Legion Dorchester Post 91 in Cambridge, Md., ... for the benefit of veteran patients, adding to a donation in the same amount ... This most recent donation from Post 91 will enable the VA Maryland Health Care ...
Breaking Medicine Technology: